Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis

Recent studies have shown that protein kinase C (PKC) delta is proteolytically activated at the onset of apoptosis induced by DNA-damaging agents, tumor necrosis factor, and anti-Fas antibody. However, the relationship of PKC delta cleavage to induction of apoptosis is unknown. The present studies d...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 184; no. 6; pp. 2399 - 2404
Main Authors Ghayur, T, Hugunin, M, Talanian, R V, Ratnofsky, S, Quinlan, C, Emoto, Y, Pandey, P, Datta, R, Huang, Y, Kharbanda, S, Allen, H, Kamen, R, Wong, W, Kufe, D
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 01.12.1996
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent studies have shown that protein kinase C (PKC) delta is proteolytically activated at the onset of apoptosis induced by DNA-damaging agents, tumor necrosis factor, and anti-Fas antibody. However, the relationship of PKC delta cleavage to induction of apoptosis is unknown. The present studies demonstrate that full-length PKC delta is cleaved at DMQD330N to a catalytically active fragment by the cysteine protease CPP32. The results also demonstrate that overexpression of the catalytic kinase fragment in cells is associated with chromatin condensation, nuclear fragmentation, induction of sub-G1 phase DNA and lethality. By contrast, overexpression of full-length PKC delta or a kinase inactive PKC delta fragment had no detectable effect. The findings suggest that proteolytic activation of PKC delta by a CPP32-like protease contributes to phenotypic changes associated with apoptosis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Address correspondence to Donald W. Kufe, Division of Cancer Pharmacology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.184.6.2399